:al MEM, to parents stated the mass had grown rapidly over he 17 cases the past week. Past medical history and family history were unremarkable. The visual acuity was 20/50 on the right and 20/30 on the left. Right ptosis (7 mm) was noted, and the right globe was displaced 2 mm temporally and 3 mm inferiorly (Fig 1) . There was no proptosis. Supraduction of the right eye was limited. A 1-5 cm firm mass was palpable protruding from under the right orbital rim in the superior nasal quadrant.
Magnetic resonance imaging showed a well F demarcated 1*8 cmx2-2 cmx2-2 cm soft tissue mass in the right superior nasal orbit. The mass was primarily in the preseptal space but extended posteriorly over the globe in the nasal quadrant to the equatorial region (Fig 2) . The sinuses and nasal cavity were normal. rior nasal A trans-septal anterior orbital biopsy was performed with debulking of the tumour. Successful treatment of MEM had been achieved by resection and chemotherapy, with or without radiation therapy to the tumour site. Given that rhabdomyosarcoma is a frequent malignant component of these tumours, it has been suggested that a chemotherapy protocol recommended for rhabdomyosarcoma would be a logical approach.3 Our patient was treated according to an IRS-III protocol. She responded well and is tumour-free with normal vision 18 months after presentation. Based on this case and reports in the literature, the appropriate treatment of MEM is maximal resection compatible with retention of function, combined with a rhabdomyosarcoma protocol of chemotherapy and radiation.
